Compare Revvity Inc (RVTY) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs GeneDx Holdings Corp — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Revvity Inc is far larger — about 6.6× GeneDx Holdings Corp's market cap, and Revvity Inc pays a 0.26% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| RVTY | WGS | |
|---|---|---|
Market Cap | $11.87B | $1.80B |
Sector | Technology | Technology |
52-Week High | $117.75 | $167.51 |
52-Week Low | $82.26 | $34.51 |
Enterprise Value | $14.36B | $1.80B |
Dividend Yield | 0.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
